A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.

计划入组 30 人 · 首次发布于 2025 年 2 月 4 日

Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

计划入组 530 人 · 首次发布于 2021 年 7 月 28 日

MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers

计划入组 20 人 · 首次发布于 2016 年 3 月 14 日

Cefepime/Zidebactam

Zidebactam

C₁₃H₂₁N₅O₇S

Cefepime

C₁₉H₂₄N₆O₅S₂ · Rx

Wockhardt Submits First Indian-Developed Antibiotic to US FDA for Multidrug-Resistant UTI Treatment

Wockhardt's Zaynich Demonstrates Superior Efficacy in Phase III cUTI Trial

Wockhardt Exits US Generics Business to Focus on Novel Antibiotic Drug Discovery